Combined use of 2-hydroxypropyl-β-cyclodextrin and a lipophilic absorption enhancer in nasal delivery of the LHRH agonist, buserelin acetate, in rats

This publication has 22 references indexed in Scilit:

• Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane
  European Journal of Pharmaceutical Sciences, 1994
• Combination effects of O-carboxymethyl-O-ethyl-β-cyclodextrin and penetration enhancer HPE-101 on transdermal delivery of prostaglandin E1 in hairless mice
  European Journal of Pharmaceutical Sciences, 1993
• Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
  International Journal of Pharmaceutics, 1992
• Potential use of 2-hydroxypropyl-.BETA.-cyclodextrin in designing nasal preparation of insulin involving lipophilic absorption enhancer HPE-101.
  Drug Delivery System, 1992
• An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys☆
  International Journal of Pharmaceutics, 1990
• Buserelin
  Drugs, 1990
• The Effects of Permeation Enhancers on the Surface Morphology of the Rat Nasal Mucosa: A Scanning Electron Microscopy Study
  Pharmaceutical Research, 1990
• Penetration and enzymatic barriers to peptide and protein absorption
  Advanced Drug Delivery Reviews, 1989
• Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)
  Antimicrobial Agents and Chemotherapy, 1989
• Effect of surfactants on the nasal absorption of insulin in rats
  International Journal of Pharmaceutics, 1981